Skip to main content
. 2019 Oct 24;22(2):267–277. doi: 10.1093/neuonc/noz155

Table 2.

Multivariable analysis excluding ECM

PFS EGFR/ALK+ NSCLC P Wild Type P
HR (95% CI) HR (95% CI)
Age (<50 vs 50–60 vs >60) 0.83 (0.60, 1.14) 0.24 0.91 (0.73, 1.14) 0.42
KPS (<70 vs 70–80 vs >80) 0.65 (0.43, 1.00) 0.05 0.73 (0.59, 0.92) 0.006
Brain mets (1 vs 2–3 vs >3) 0.92 (0.69, 1.22) 0.56 1.22 (1.02, 1.46) 0.029
Symptomatic 1.11 (0.64, 1.92) 0.71 1.05 (0.74, 1.49) 0.80
Synchronous 0.75 (0.45, 1.24) 0.26 0.79 (0.58, 1.07) 0.12
OS
Age (<50 vs 50–60 vs >60) 1.28 (0.88, 1.86) 0.20 1.05 (0.84, 1.33) 0.65
KPS (<70 vs 70–80 vs >80) 0.35 (0.22, 0.55) <0.001 0.70 (0.56, 0.89) 0.004
Brain mets (1 vs 2–3 vs >3) 0.95 (0.69, 1.31) 0.74 1.31 (1.08, 1.59) 0.006
Symptomatic 0.87 (0.48, 1.60) 0.66 0.97 (0.67, 1.40) 0.85
Synchronous 0.69 (0.40, 1.19) 0.18 0.83 (0.60, 1.15) 0.25